Benzinga.com27m
EXCLUSIVE: Trump's Guilty Verdict Sparks Brief Overreaction In 2024 Election Betting Odds, But He 'Remains The Favorite To Be The Next President'
Donald Trump was found guilty on 34 federal charges Thursday. Trump can still run for president and remains the betting favorite in the 2024 election. Loading ...
Benzinga.com27m
Here's How Much You Would Have Made Owning Linde Stock In The Last 20 Years
Linde LIN has outperformed the market over the past 20 years by 5.08% on an annualized basis producing an average annual return of 13.0%. Currently, Linde has a market capitalization of $209.36 ...
Benzinga.com27m
Delaware Expands Medical Cannabis Access, Grants Physicians Discretion For Recommendations, Opens Dispensaries To Out-Of-State Patients
Delaware allows seniors 65+ to self-certify for medical cannabis cards without a doctor's recommendation. Physicians now have the freedom to recommend medical cannabis for any condition, enhancing ...
Benzinga.com27m
AMD, TSMC, Broadcom And Other Chip Stocks Hit By Biden's Fresh AI Chip Export Restrictions: Details
Biden's embargo on AI chip exports to the Middle East triggers a sector-wide selloff, impacting ETFs SMH and SOXX by nearly 3%. Nvidia, AMD, and other chip stocks like TSM, Broadcom, and Qualcomm ...
Benzinga.com27m
5 Celebrities Who Are Surprisingly Good At Managing Their Money
Dreaming of a day when counting cents is history? Well, not everyone's tossing their budget sheets once they hit the jackpot. Even with bank accounts that could rival a small country’s GDP, some ...
Benzinga.com27m
Nvidia Is South Korea's Favorite Foreign Stock: Jensen Huang's Chip Company Can't Stop Winning
Nvidia is a popular stock in the United States and recently hit a top ranking in South Korea. The chip maker stock has soared over the last year and is still widely ...
Benzinga.com27m
Pfizer Highlights 'Unprecedented' 5 Year Data From Cancer Drug In Rare Form Of Advanced Lung Cancer
In this updated analysis, Lorbrena showed a 94% reduction in the risk of developing intracranial progression. Pfizer expects its cancer drug Lorbrena to top $1 billion in annual sales by 2030. After ...
Benzinga.com27m
Critical Insights From Calliditas Therapeutics Analyst Ratings: What You Need To Know
In the last three months, 5 analysts have published ratings on Calliditas Therapeutics CALT, offering a diverse range of perspectives from bullish to bearish. The table below offers a condensed view ...
Benzinga.com27m
MGM Resorts Intl Unusual Options Activity For May 31
Deep-pocketed investors have adopted a bullish approach towards MGM Resorts Intl MGM, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled ...
Benzinga.com27m
(CAG) - Analyzing Conagra Brands's Short Interest
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...
$100 Invested In CDW 5 Years Ago Would Be Worth This Much Today
Buying $100 In CDW: If an investor had bought $100 of CDW stock 5 years ago, it would be worth $225.06 today based on a price of $223.62 for CDW at the time of writing.
Here's How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 10 Years
Thermo Fisher Scientific TMO has outperformed the market over the past 10 years by 6.43% on an annualized basis producing an average annual return of 16.92%. Currently, Thermo Fisher Scientific has a ...